Advertisement

European Journal of Clinical Pharmacology

, Volume 37, Issue 1, pp 1–5 | Cite as

Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure

  • G. La Villa
  • F. Marra
  • G. Laffi
  • B. Belli
  • E. Meacci
  • P. Fascetti
  • P. Gentilini
Originals

Summary

In a randomized double-blind cross-over study the effects of rhein (administered as diacetylrhein 50 mg b.d. for 5 days) and placebo on renal arachidonic acid metabolism and renal function have been compared in 12 elderly patients (mean age 75.2 years) with congestive heart failure, whose renal function was known to be dependent on the integrity of the renal prostaglandin system.

Rhein like placebo, did not induce any change in the urinary excretion of prostaglandin (PG) E2, 6-keto-PGF and thromboxane (TX) B2, nor did it affect creatinine clearance, blood urea, urine output, natriuresis, body weight, plasma renin activity or plasma aldosterone concentration. Separate analysis of the results obtained in the 5 patients receiving diuretic treatment did not show any significant effect of rhein as compared with placebo on the parameters investigated. Serum TXB2 concentration during whole blood clotting, as an index of platelet arachidonic acid metabolism, also showed no significant difference when DAR and placebo were compared.

It is concluded that in patients with congestive heart failure rhein does not inhibit renal or platelet eicosanoid metabolism, nor does it modify renal function, sodium excretion or the renal response to diuretics.

Key words

congestive heart failure rhein non-steroidal antiinflammatory drugs (NSAIDs) renal prostaglandins renal function serum thromboxane side-effects 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dunn MJ (1987) Renal prostaglandins. In: Klahr S, Massry SG (eds) Contemporary nephrology, vol. 4. Plenum Publishing, New YorkGoogle Scholar
  2. 2.
    McKay IG, Muir AL, Watson ML (1984) Contribution of prostaglandins to the systemic and renal vascular response to furosemide in normal man. Br J Clin Pharmacol 17: 513–519Google Scholar
  3. 3.
    Brater DC, Anderson S, Baird B, Campbell WB (1985) Effects of ibuprofen, naproxen and sulindac on prostaglandins in men. Kidney Int 27: 66–73Google Scholar
  4. 4.
    Kramer HJ, Düsing R, Stinnesbeck B, Prior W, Bäcker A, Eden J, Kipnowski J, Glänzer K, Krück F (1980) Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin Sci 59: 67–70Google Scholar
  5. 5.
    Groene HJ, Dunn MJ (1985) The role of prostaglandins in arterial hypertension: A critical review. Adv Nephrol 14: 241–272Google Scholar
  6. 6.
    Kay AGL, Griffiths LG, Volans GN, Grahame R (1980) Preliminary experience with diacetylrhein in the treatment of osteoarthritis. Curr Med Res Opin 6: 548–551Google Scholar
  7. 7.
    Neuman M (1980) Clinical, biological and gastric fibroscopic tolerance of a new non-steroidal anti-inflammatory analgesic, diacetylrhein. Drug Exp Clin Res 6: 53–64Google Scholar
  8. 8.
    Lingetti M, D'Ambrosio PL, Di Grezia F, Sorrentino P, Lingetti E (1982) A controlled study in the treatment of osteoarthritis with diacetylrhein. Curr Therap Res 31: 408–411Google Scholar
  9. 9.
    Pomarelli P, Berti M, Gatti MT, Mosconi P (1980) A non steroidal anti-inflammatory drug that stimulates prostaglandin release. Il Farmaco Ed Sci 35: 836–842Google Scholar
  10. 10.
    Franchi-Micheli S, Lavacchi L, Friedmann CA, Zilletti L (1983) The influence of rhein on the biosynthesis of prostaglandin-like substances in vitro. J Pharm Pharmacol 35: 262–264Google Scholar
  11. 11.
    Frolich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins; identification and origin. J Clin Invest 55: 763–770Google Scholar
  12. 12.
    Watson ML, Gill JR, Branch RA, Oates JA, Brash AR (1983) Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. Lancet 2: 368–370Google Scholar
  13. 13.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A (1985) Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 76: 1011–1018Google Scholar
  14. 14.
    Patrono C, Dunn MJ (1987) The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32: 1–12Google Scholar
  15. 15.
    Laffi G, La Villa G, Pinzani M, Ciabattoni G, Patrignani P, Mannelli M, Cominelli F, Gentilini P (1986) Altered renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology 90: 274–282Google Scholar
  16. 16.
    Criteria Committee of the New York Heart Association (1964) Diseases of the heart and great vessels. Nomenclature and criteria for diagnosis, 6th edn. Little Brown, BostonGoogle Scholar
  17. 17.
    Gentilini P, Laffi G, Meacci E, La Villa G, Cominelli F, Pinzani M, Buzzelli G (1988) Effects of OKY 046, a thromboxanesynthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. Gastroenterology 94: 1470–1477Google Scholar
  18. 18.
    Zipser RD, Morrison A, Laffi G, Duke R (1985) Assay methods for 6-keto-prostaglandin F1. in human urine: Comparison of chromatography techniques with radioimmunoassay and gas chromatography-negative ion chemical ionization mass spectrometry. J Chromatogr 339: 1–9Google Scholar
  19. 19.
    Laffi G, La Villa G, Cominelli F, Chelli M, Pinzani M, Tosti-Guerra C, Birardi A, Paladini S, Simoni A, Gentilini P (1988) Purification of PGE2 in the urine of cirrhotic patients: Comparison of three chromatographic techniques. J Nucl Med Allied Sci 32: 67–74Google Scholar
  20. 20.
    Meacci E, La Villa G, Laffi G, Cominelli F, Di Donato M, Dabizzi P, Albani F, Gentilini P (1987) Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosis. Liver 7: 110–115Google Scholar
  21. 21.
    Patrono C, Ciabattoni G, Filabozzi P, Catella F, Forni L, Segni M, Patrignani P, Pugliese F, Simonetti BM, Pierucci A (1984) Drugs, prostaglandins and renal function. In: Neri Serneri GG, McGiff JC, Paoletti R, Born GVR (eds) Advances in prostaglandin, thromboxane, and leukotriene research, vol. 13. Raven Press, New YorkGoogle Scholar
  22. 22.
    Dunn MJ (1984) Non-steroidal anti-inflammatory drugs and renal function. Ann Rev Med 35: 411–428Google Scholar
  23. 23.
    Walshe JJ, Venuto RC (1979) Acute oliguric renal failure induced by indomethacin: possible mechanism. Ann Int Med 91: 47–49Google Scholar
  24. 24.
    Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C (1984) Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 310: 279–283Google Scholar
  25. 25.
    Arisz L, Donker AJM, Brentjens JRH, van der Hem GK (1976) The effects of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 199: 121–125Google Scholar
  26. 26.
    Wilcox RG, Richardson D, Hampton JR, Mitchell JR, Banks DC (1980) Sulphinpyrazone in acute myocardial infarction: Studies on cardiac rhythm and renal function. Br Med J 281: 531–534Google Scholar
  27. 27.
    Laffi G, Daskalopoulos G, Kronborg I, Hsueh W, Gentilini P, Zipser RD (1986) Effects of sulindac and ibuprofen in patients with cirrhosis and ascites: An explanation for the renal-sparing effect of sulindac. Gastroenterology 90: 182–187Google Scholar
  28. 28.
    Brater DC (1979) Analysis of the effect of indomethacin on the response to furosemide in man: Effect of dose of furosemide. J Pharmacol Exp Ther 210: 386–390Google Scholar
  29. 29.
    Berg KJ, Loew D (1979) Inhibition of furosemide-induced natriuresis by acetyl salicylic acid in dogs. Scand J Clin Lab Invest 37: 125–131Google Scholar
  30. 30.
    Tiggeler RGWL, Koene RAP, Wijdeveld PGAB (1977) Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome. Clin Sci Mol Med 52: 149–151Google Scholar
  31. 31.
    Daskalopoulos G, Kronborg I, Katkov W, Gonzales M, Laffi G, Zipser RD (1985) Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: Evidence that sulindac affects renal prostaglandins. Am J Kidney Dis 6: 217–221Google Scholar
  32. 32.
    Raimondi L, Banchelli Soldaini G, Buffoni F, Ignesti G, Massacesi L, Amaducci L, Friedmann CA (1982) Rhein and derivatives. In vitro studies on their capacity to inhibit some proteases. Pharm Res Commun 14: 103–112Google Scholar
  33. 33.
    Mian M, Brunelleschi S, Tarli S, Rubino A, Benetti D, Fantozzi R, Zilletti L (1987) Rhein: An antraquinone that modulates superoxide anion production from human neutrophils. J Pharma Pharmacol 39: 845–847Google Scholar
  34. 34.
    Bianchi-Porro G, Ardizzone S, Caruso I, Montrone F (1987) Valutazione endoscopica degli effetti della diacereina e del naprossene sulla mucosa gastroduodenale. Min Med 78: 411–413Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • G. La Villa
    • 1
  • F. Marra
    • 1
  • G. Laffi
    • 1
  • B. Belli
    • 1
  • E. Meacci
    • 1
  • P. Fascetti
    • 2
  • P. Gentilini
    • 1
  1. 1.Istituto di Clinica Medica IIUniversity of Florence School of MedicineItaly
  2. 2.Istituto GentiliPisaItaly

Personalised recommendations